investor login
contact
team
dedicated funds
news
portfolio
Discover the
Latest
browse by categories
hatteras venture partner news
Portfolio Company News
Hatteras blogs
browse by categories
Search for:
Hatteras Venture Partners News
Venture firm gets creative to hold meetings at crowded SF conference
January 15, 2026
Hatteras Venture Partners Honors HistoSonics with the Charles A. Sanders Award for Entrepreneurial Excellence
November 6, 2025
Hatteras Venture Partners Raises Over $200 Million in Capital Across Two Healthcare-Focused Funds
August 13, 2025
A top Research Triangle based venture capital investor shares an overview of the life sciences ecosystem in North Carolina.
May 22, 2024
They’re Back – Will We See the M&A Boon? Hatteras White Paper on Biotech M&A
May 11, 2022
Business North Carolina’s Power List 2021
May 5, 2021
Hatteras Venture Partners Announces First Closing of HVP VI
April 15, 2019
CEO Roundtable on Cancer Presents Dr. Charles A. Sanders Life Sciences Award to Jean Becker, Ken Lee and Phil Porter
November 19, 2018
Sir Andrew Witty Joins Hatteras Venture Partners
September 19, 2017
Hatteras Venture Partners Announces Launch of the Venture Capital Multiplier Fund
February 28, 2017
Hatteras Venture Partners Announces the Final Closing of Hatteras Venture Partners V, LP
January 5, 2017
Hatteras Venture Partners Earns CEO Cancer Gold Standard Accreditation
April 25, 2016
TBJ names 2016 Women in Business Lifetime Achievement Award winner
March 7, 2016
Carolina Research Ventures Selects Hatteras as Manager of Investments
March 2, 2016
Hatteras Venture Partners Announces First Closing of HVP V
August 25, 2015
UNC Kenan-Flagler Distinguished Alumni Award
November 21, 2013
“IMPACT: The Art and Science of Making a Difference”
August 12, 2013
Triangle has become epicenter of global CRO industry
June 24, 2013
Hatteras leads NeuroTronik Series A financing
June 13, 2013
TiE Atlanta awarded Christy Shaffer the 2013 Venture Capital Entrepreneur Award at the TieCON Southeast conference
May 6, 2013
Robert Ingram wins Life Science Leadership Award at 2013 CED Life Sciences Conference
March 1, 2013
HVP III Portfolio Company Clinipace Worldwide makes Top 40 on FORBES’ Most Promising Companies List
February 11, 2013
Hatteras Venture Partners Announces the Final Closing of Hatteras Venture Partners IV, LP
January 7, 2013
Hatteras Venture Partners Announces the First Closing of HVP IV, LP
August 16, 2011
Hatteras Announces Significant Realizations in HVP II – Trade Sales of B.R.A.H.M.S. and ESBATech Result in Full Return of Paid-in Capital to Limited Partners
October 8, 2009
Hatteras Announces Its Scientific Advisory Board
May 20, 2008
Hatteras Announces Initial Closing of Fund Focused on Early-Stage Companies in the Southeast
February 9, 2007
contact
team
dedicated funds
news
home
portfolio
